<i>BCL3</i> rearrangements in B-cell lymphoid neoplasms occur in two breakpoint clusters associated with different diseases
Anna Carbó-Meix(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Elı́as Campo(Hospital Clínic de Barcelona), Guillem Clot(Aristotle University of Thessaloniki), Alberto Pineda(Hospital de l'Esperança), Romina Royo(Barcelona Supercomputing Center), Mariana Fernández‐Caballero(Universitat Autònoma de Barcelona), Gabriella De Canal, Fina Climent, Martí Duran‐Ferrer(Universitat de Barcelona), Luojun Wang(Xijing Hospital), José I. Martín‐Subero(Institució Catalana de Recerca i Estudis Avançats), Steven H. Swerdlow(University of Pittsburgh), Gerard Frigola(Hospital Clínic de Barcelona), Heribert Playà-Albinyana(Centro de Investigación Biomédica en Red de Cáncer), Marco M. Bühler(University Hospital Zurich), Marta Grau(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Isabel Granada(Josep Carreras Leukaemia Research Institute), Marta Aymerich(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Pierre Brousset(Université Toulouse III - Paul Sabatier), Charlotte Syrykh(Institut universitaire du cancer de Toulouse Oncopole), Ferran Nadeu(Centro de Investigación Biomédica en Red de Cáncer), Esperanza Tuset(Hospital Del Mar), Blanca Espinet(Hospital Del Mar), Lucrecia Yáñez(Universidad de Cantabria), Marı́a Rozman(Universitat de Barcelona), Inmaculada Ribera‐Cortada(University of Andorra), James R. Cook(Cleveland Clinic), Dolors Costa(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Janilson Do Nascimento(Institut Català d'Oncologia), Anna Puiggros(Hospital Del Mar), Junyan Lu(Heidelberg University), Gustavo Tapia(Hospital Universitari Germans Trias i Pujol), Estella Matutes(Institute of Cancer Research), Sı́lvia Beà(Departament de Salut), Dolors Colomer(Hospital Clínic de Barcelona), Laura Bandiera, Maria João Baptista(Josep Carreras Leukaemia Research Institute), Jesus Xavier Ortin(Hospital Universitari de Tortosa Verge de la Cinta), Emanuela Bonoldi, Esmeralda de la Banda(Bellvitge University Hospital), Miguel Perera(Hospital Universitario de Gran Canaria Doctor Negrín), Thorsten Zenz(Universität Ulm), Dolors Vela(Hospital General de Granollers), Francesca Guijarro(Hospital Clínic de Barcelona)
Cited by 13
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k